文献速递先天性心脏病外科瓣膜外科

活检检出的心肌纤维化可预测法洛四联症修复术后肺动脉瓣置换患者的不良心脏事件

Biopsy-detected myocardial fibrosis predicts adverse cardiac events after pulmonary valve replacement in patients with repaired tetralogy of Fallot.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

该研究连续纳入51例接受外科肺动脉瓣置换的修复型法洛四联症患者,术中取右室流出道组织以自动图像分析法测定组织学心肌纤维化程度。中位随访4.9年,14例发生不良心脏事件;心肌纤维化程度(HR 1.127,95%CI 1.047-1.213,P=0.001)与肺动脉瓣置换时年龄(HR 1.062,95%CI 1.010-1.116,P=0.019)与不良心脏事件风险升高相关。

要点

  • 心肌纤维化中位百分比为20.6%(四分位距16.7-27.0%),发生心脏事件者高于未发生者(24.1% vs 19.7%,P=0.007)。
  • 心肌纤维化(HR 1.127,95%CI 1.047-1.213,P=0.001)与肺动脉瓣置换时年龄(HR 1.062,95%CI 1.010-1.116,P=0.019)是不良心脏事件的独立危险因素。
  • 心肌纤维化>20.1%且肺动脉瓣置换时年龄>18.2岁时不良心脏事件发生率显著升高。

核心结论

  • 组织学心肌纤维化与修复型法洛四联症患者双心室收缩功能相关。
  • 较高的心肌纤维化程度和较大的肺动脉瓣置换时年龄是肺动脉瓣置换术后不良心脏事件的独立危险因素。

研究设计与样本

  • 连续收集51例接受外科肺动脉瓣置换的修复型法洛四联症患者的临床、心脏磁共振、超声心动图和心电图数据。
  • 肺动脉瓣置换术中采集右室流出道组织,采用天狼星红染色定制自动图像分析方法测定组织学心肌纤维化程度。

主要发现

  • 中位随访时间4.9年,随访期间14例发生不良心脏事件(心力衰竭入院和心律失常的复合终点)。
  • 心肌样本总分析面积为5782.18 mm²,心肌纤维化中位百分比为20.6%(四分位距16.7-27.0%)。
  • 发生不良心脏事件者心肌纤维化百分比高于未发生者(24.1% vs 19.7%,P=0.007)。
  • 多变量逐步线性回归分析显示右心室射血分数和左心室收缩末期容积指数与心肌纤维化显著相关(R²=0.238)。
  • Cox比例风险回归显示心肌纤维化程度(HR 1.127,95%CI 1.047-1.213,P=0.001)和肺动脉瓣置换时年龄(HR 1.062,95%CI 1.010-1.116,P=0.019)与不良心脏事件风险升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Risk factors associated with adverse cardiac events (cardiac AEs) after pulmonary valve replacement (PVR) in patients with repaired tetralogy of Fallot are incompletely understood. In this study, we aimed to determine the relationship between histological myocardial fibrosis and cardiac AEs after PVR in patients with rTOF. METHODS: We consecutively collected clinical, cardiac magnetic resonance, echocardiography and electrocardiogram data of 51 patients with rTOF who underwent surgical PVR. The right ventricular outflow tract tissue was collected during the PVR and the degree of histological myocardial fibrosis was determined by a tailor-made automated image analysis method of picrosirius red staining. RESULTS: The median follow-up time was 4.9 years, and 14 patients had cardiac AEs (a composite of heart failure admission and arrhythmia) during follow-up. The total analysis area of myocardial samples was 5782.18 mm2, and the median percentage of myocardial fibrosis was 20.6% (interquartile range 16.7-27.0%), which were significantly elevated in patients with cardiac AEs compared with patients without cardiac AEs (24.1% vs 19.7%, P = 0.007). Right ventricular ejection fraction and left ventricular end-systolic volume index were significantly associated with myocardial fibrosis in multivariable stepwise linear regression analysis (R2 = 0.238). Cox proportional hazards regression identified degree of myocardial fibrosis [hazard ratio 1.127; 95% confidence interval (CI) 1.047-1.213; P = 0.001] and age at PVR (hazard ratio 1.062; 95% CI 1.010-1.116; P = 0.019) were associated with increased risk of cardiac AEs. The incidence of adverse cardiac events was significantly increased when myocardial fibrosis >20.1% and age at PVR >18.2 years. CONCLUSIONS: Histological myocardial fibrosis was associated with biventricular systolic functions in rTOF. Higher myocardial fibrosis and older age at PVR are independent risk factors for the adverse cardiac events after PVR in patients with rTOF.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yuan J, Su Z, Wang G, et al. Biopsy-detected myocardial fibrosis predicts adverse cardiac events after pulmonary valve replacement in patients with repaired tetralogy of Fallot. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 36931282. doi:10.1093/icvts/ivad023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。